Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial.
Farajzadeh S, Hakimi Parizi M, Haghdoost AA, Mohebbi A, Mohammadi S, Pardakhty A, Eybpoosh S, Heshmatkhah A, Vares B, Saryazdi S, Fekri AR, Mohebbi E. Farajzadeh S, et al. Among authors: heshmatkhah a. J Parasit Dis. 2016 Sep;40(3):935-9. doi: 10.1007/s12639-014-0609-1. Epub 2014 Nov 22. J Parasit Dis. 2016. PMID: 27605813 Free PMC article.
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
Aflatoonian MR, Sharifi I, Aflatoonian B, Bamorovat M, Heshmatkhah A, Babaei Z, Ghasemi Nejad Almani P, Mohammadi MA, Salarkia E, Aghaei Afshar A, Sharifi H, Sharifi F, Khosravi A, Khatami M, Arefinia N, Fekri A, Farajzadeh S, Khamesipour A, Mohebali M, Gouya MM, Shirzadi MR, Varma RS. Aflatoonian MR, et al. Among authors: heshmatkhah a. PLoS Negl Trop Dis. 2019 Jun 12;13(6):e0007423. doi: 10.1371/journal.pntd.0007423. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31188834 Free PMC article.
Quality of life in patients with cutaneous leishmaniasis.
Vares B, Mohseni M, Heshmatkhah A, Farjzadeh S, Safizadeh H, Shamsi-Meymandi S, Rahnama Z, Reghabatpour L, Fathi O. Vares B, et al. Among authors: heshmatkhah a. Arch Iran Med. 2013 Aug;16(8):474-7. Arch Iran Med. 2013. PMID: 23906253
Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment.
Bamorovat M, Sharifi I, Aflatoonian MR, Karamoozian A, Tahmouresi A, Jafarzadeh A, Heshmatkhah A, Sharifi F, Salarkia E, Khaleghi T, Khosravi A, Nooshadokht M, Zarandi MB, Barghi M. Bamorovat M, et al. Among authors: heshmatkhah a. Int J Infect Dis. 2022 Sep;122:155-161. doi: 10.1016/j.ijid.2021.09.050. Epub 2021 Sep 24. Int J Infect Dis. 2022. PMID: 34571149 Free PMC article.
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Bamorovat M, Sharifi I, Fekri A, Keyhani A, Aflatoonian MR, Heshmatkhah A, Oliaee RT, Khosravi A, Naderi A, Parizi MH, Mostafavi M, Varma RS. Bamorovat M, et al. Among authors: heshmatkhah a. Microb Pathog. 2019 Mar;128:162-170. doi: 10.1016/j.micpath.2018.12.040. Epub 2018 Dec 21. Microb Pathog. 2019. PMID: 30583021
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
Oliaee RT, Sharifi I, Afgar A, Kareshk AT, Asadi A, Heshmatkhah A, Bamorovat M, Jafarzadeh A, Mohammadi MA, Daneshvar H. Oliaee RT, et al. Among authors: heshmatkhah a. Trop Med Int Health. 2018 Jun;23(6):622-633. doi: 10.1111/tmi.13062. Epub 2018 May 21. Trop Med Int Health. 2018. PMID: 29709098 Free article.
15 results